SCHEMBL28325321

SCHEMBL28325321

O=[N+]([O-])c1cccnc1S(=O)(=O)c1ccncc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.80
MEN1 O00255 3/20 0.80
RAB9A P51151 2/20 0.80
PAX8 Q06710 2/20 0.76
TXNRD1 Q16881 5/20 0.57
ALDH1A1 P00352 1/20 0.48
PDE10A Q9Y233 1/20 0.45
MAPT P10636 3/20 0.45
S1PR4 O95977 2/20 0.45
S1PR1 P21453 2/20 0.45
MAPK1 P28482 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
GFER P55789 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
POLB P06746 1/20 0.44
MET P08581 1/20 0.42
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18497242 0.89 KMT2A (1.00) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL18497237 0.86 KMT2A (0.78) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL18497234 0.86 PAX8 (1.00) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL27846900 0.85 KMT2A (0.76) KMT2AMEN1RAB9APAX8TXNRD1
Hydrochloric Acid SCHEMBL18497226 0.85 PAX8 (0.97) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL28217707 0.82 KMT2A (0.72) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL20476787 0.82 KMT2A (0.71) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL4014550 0.79 MEN1 (0.67) KMT2AMEN1RAB9APAX8ALDH1A1
Trifluoroacetic Acid SCHEMBL18497239 0.79 KMT2A (0.80) KMT2AMEN1RAB9APAX8TXNRD1
SCHEMBL4014551 0.79 MEN1 (0.67) KMT2AMEN1RAB9APAX8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110382486-A Heteroaryl sulfonyl substituted pyridines and their use in the treatment of cancer 欧比力克治疗公司 2019-10-25 CN disclosed